
NOTV
Inotiv Inc.
Company Overview
| Mkt Cap | $40.19M | Price | $0.76 |
| Volume | 207.53K | Change | -4.91% |
| P/E Ratio | -0.4 | Open | $0.80 |
| Revenue | $490.7M | Prev Close | $0.80 |
| Net Income | $-108.4M | 52W Range | $0.66 - $6.48 |
| Div Yield | N/A | Target | $4.83 |
| Overall | 40 | Value | 60 |
| Quality | 44 | Technical | 18 |
No chart data available
About Inotiv Inc.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Latest News
Inotiv, Inc. Faces Business Risks Amid FDA Disruptions and Government Funding Challenges
Inotiv, Inc. Earnings Call: Growth Amid Challenges
Lake Street Keeps Their Buy Rating on Inotiv (NOTV)
Inotiv, Inc. Reports Improved Fiscal 2025 Results
Analysts Are Bullish on Top Healthcare Stocks: Evolus (EOLS), Inotiv (NOTV)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NOTV | $0.76 | -4.9% | 207.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |